English Overview
The discussion will cover several aspects of Cardiovascular protection and Glycemic Control of Once Weekly Dulaglutide
This Activity for
- Resident / Fellow
- Physician
What I will learn?
1- HCPs to understand different cardiovascular trials design and patient population distribution.
2- Understand the difference between primary and secondary CV protection.
3- Understand the results of recent CV trials for Once-weekly dulaglutide and its implications on T2D patients.
2- Understand the difference between primary and secondary CV protection.
3- Understand the results of recent CV trials for Once-weekly dulaglutide and its implications on T2D patients.
Speakers 1 Distinguished Speakers
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Once Weekly Dulaglutide Cardiovascular protection and Glycemic Control for T2D Certificate
Certificate |
Certificate | Free |
VAT 15% Included
